Senores Pharmaceuticals (NSE:SENORES) Change In Inventory: ₹0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SENORES Senores Pharmaceuticals Ltd NSE:SENORES
19 GF Score
Price ₹1,513.30
! 7 Warning Signs
View Full Analysis

What is Senores Pharmaceuticals Change In Inventory?

Senores Pharmaceuticals NSE:SENORES 19 Change In Inventory is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:SENORES with a GF Score™ of 19/100. The stock has 7 warning signs investors should review.

Senores Pharmaceuticals's change in inventory for the quarter that ended in Jun. 2026 was ₹0 Mil. It means Senores Pharmaceuticals's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Senores Pharmaceuticals's change in inventory for the fiscal year that ended in Mar. 2026 was ₹-303 Mil. It means Senores Pharmaceuticals's inventory increased by ₹303 Mil from Mar. 2025 to Mar. 2026 .

Senores Pharmaceuticals's Total Inventories for the quarter that ended in Jun. 2026 was ₹0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Senores Pharmaceuticals's Days Inventory for the quarter that ended in Jun. 2026 was 61.99.

Inventory Turnover measures how fast the company turns over its inventory within a year. Senores Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2026 was 1.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Senores Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.25.

Senores Pharmaceuticals  (NSE:SENORES) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Senores Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=446.45/657.2*365 / 4
=61.99

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Senores Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=657.2 / 446.45
=1.47

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Senores Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=446.45 / 1802.1
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senores Pharmaceuticals Change In Inventory Related Terms

Senores Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for Senores Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senores Pharmaceuticals Change In Inventory Chart

Senores Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
-26.44 -1.42 -10.40 -192.60 -303.40

Senores Pharmaceuticals Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:SENORES
19GF Score
Senores Pharmaceuticals Ltd NSE:SENORES
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senores Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of ₹0 Mil mean?
Senores Pharmaceuticals (NSE:SENORES) has a Change In Inventory of ₹0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Senores Pharmaceuticals and its competitors.
Is Senores Pharmaceuticals' Change In Inventory too high?
Senores Pharmaceuticals' current Change In Inventory is ₹0 Mil. Overall, Senores Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Senores Pharmaceuticals' Change In Inventory compare to LLY and JNJ?
Senores Pharmaceuticals' Change In Inventory of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Senores Pharmaceuticals and its competitors. Senores Pharmaceuticals's current Change In Inventory is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senores Pharmaceuticals stock overvalued right now?
Senores Pharmaceuticals (NSE:SENORES) has a current Change In Inventory of ₹0 Mil. The current Change In Inventory is ₹0 Mil. Senores Pharmaceuticals' overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Senores Pharmaceuticals (NSE:SENORES), the current Change In Inventory is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Senores Pharmaceuticals Business Description

Other Exchanges 544319:India
Address Ambali Bopal Road, 1101 to 1103, 11th floor, South Tower, ONE 42, Opposite Jayantilal Park, Ahmedabad, GJ, IND, 380054
Senores Pharmaceuticals Ltd is a research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for the Regulated Markets of the USA, Canada and United Kingdom across various therapeutic areas and dosage forms, with a presence in Emerging Markets. Its strength lies in identifying, developing and manufacturing a diverse range of specialty, underpenetrated and complex pharmaceutical products establishing the company as a preferred partner to certain customers. Through data analytics, research, market assessment and experienced management, It strategically identifies commercially underpenetrated molecules to launch products in the Regulated and Emerging Markets.
19GF Score

Get the complete analysis for NSE:SENORES

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,513.30
Price